Response of the cerebral vasculature following traumatic brain injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 7, 2017, Pages 2320-2339

  Salehi, Arjang ^a,b   Zhang, John H ^c   Obenaus, Andre ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; brain trauma; neurovascular unit; regeneration and recovery; vasculogenesis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BETA CATENIN; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; CLAUDIN 5; ENDOTHELIN 1; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; PHOSPHOLIPASE C GAMMA; RHO FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBOPLASTIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR; WNT PROTEIN; VASCULOTROPIN A;

AGE; ANGIOGENESIS; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD CLOTTING DISORDER; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN DYSFUNCTION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERICYTE; BRAIN VASOSPASM; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; CLINICAL OUTCOME; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; HYDROGEL; MACROPHAGE; MEMBRANE DAMAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIVASCULAR MACROPHAGE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE COUNT; TISSUE OXYGENATION; TRAUMATIC BRAIN INJURY; WNT SIGNALING PATHWAY; ANIMAL; BRAIN ARTERY; BRAIN CIRCULATION; BRAIN VEIN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BIOMARKERS; BLOOD-BRAIN BARRIER; BRAIN INJURIES, TRAUMATIC; CEREBRAL ARTERIES; CEREBRAL VEINS; CEREBROVASCULAR CIRCULATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85021089108     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X17701460     Document Type: Review

References (210)

1. Kabadi SV, Faden AI. Neuroprotective strategies for traumatic brain injury: Improving clinical translation. Int J Mol Sci 2014; 15: 1216–1236.
2. Logsdon AF, Lucke-Wold BP, Turner RC. Role of microvascular disruption in brain damage from traumatic brain injury. Compr Physiol 2015; 5: 1147–1160.
3. Kenney K, Amyot F, Haber M. Cerebral vascular injury in traumatic brain injury. Exp Neurol 2016; 275(Pt 3): 353–366.
4. Jullienne A, Obenaus A, Ichkova A. Chronic cerebrovascular dysfunction after traumatic brain injury. J Neurosci Res 2016; 94: 609–622.
5. Zhang JH, Badaut J, Tang J. The vascular neural network – A new paradigm in stroke pathophysiology. Nat Rev Neurol 2012; 8: 711–716.
6. Jullienne A, Badaut J. Molecular contributions to neurovascular unit dysfunctions after brain injuries: Lessons for target-specific drug development. Future Neurol 2013; 8: 677–689.
7. Morgan R, Kreipke CW, Roberts G. Neovascularization following traumatic brain injury: Possible evidence for both angiogenesis and vasculogenesis. Neurol Res 2007; 29: 375–381.
8. Frontczak-Baniewicz M, Walski M. New vessel formation after surgical brain injury in the rat's cerebral cortex I. Formation of the blood vessels proximally to the surgical injury. Acta Neurobiol Exp 2003; 63: 65–75.
9. Park E, Bell JD, Siddiq IP. An analysis of regional microvascular loss and recovery following two grades of fluid percussion trauma: A role for hypoxia-inducible factors in traumatic brain injury. J Cereb Blood Flow Metab 2009; 29: 575–584.
10. Rosenbaum BP, Kelly ML, Kshettry VR. Neurologic disorders, in-hospital deaths, and years of potential life lost in the USA, 1988-2011. J Clin Neurosci 2014; 21: 1874–1880.
11. Corrigan JD, Selassie AW, Orman JA. The epidemiology of traumatic brain injury. J Head Trauma Rehabil 2010; 25: 72–80.
12. Maas AI, Menon DK, Steyerberg EW. Collaborative European neurotrauma effectiveness research in traumatic brain injury (CENTER-TBI): A prospective longitudinal observational study. Neurosurgery 2015; 76: 67–80.
13. Vaishnavi S, Rao V, Fann JR. Neuropsychiatric problems after traumatic brain injury: Unraveling the silent epidemic. Psychosomatics 2009; 50: 198–205.
14. Selassie AW, Zaloshnja E, Langlois JA. Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil 2008; 23: 123–131.
15. Johnson VE, Meaney DF, Cullen DK. Animal models of traumatic brain injury. Handb Clin Neurol 2015; 127: 115–128.
16. Guskiewicz KM, Marshall SW, Bailes J. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery 2005; 57: 719–726; discussion 26.
17. Yeh DD, Schecter WP. Primary blast injuries – An updated concise review. World J Surg 2012; 36: 966–972.
18. Benson RR, Gattu R, Sewick B. Detection of hemorrhagic and axonal pathology in mild traumatic brain injury using advanced MRI: Implications for neurorehabilitation. Neurorehabilitation 2012; 31: 261–279.
19. Konrad C, Geburek AJ, Rist F. Long-term cognitive and emotional consequences of mild traumatic brain injury. Psychol Med 2011; 41: 1197–1211.
20. Obenaus A. Traumatic brain injury. Encyclopedia of mental health. 2nd ed. Oxford: Elsevier, 2015, pp.329–340
21. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 2008; 7: 728–741.
22. Spitz G, Alway YJ, Gould K. Disrupted white matter microstructure and mood disorders following traumatic brain injury. J Neurotrauma 2016; 34: 807–815.
23. Lozano D, Gonzales-Portillo GS, Acosta S. Neuroinflammatory responses to traumatic brain injury: Etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat 2015; 11: 97–106.
24. Pop V, Badaut J. A neurovascular perspective for long-term changes after brain trauma. Transl Stroke Res 2011; 2: 533–545.
25. Perel P, Roberts I, Bouamra O. Intracranial bleeding in patients with traumatic brain injury: A prognostic study. BMC Emerg Med 2009; 9: 15.
26. Hochstadter E, Stewart TC, Alharfi IM. Subarachnoid hemorrhage prevalence and its association with short-term outcome in pediatric severe traumatic brain injury. Neurocrit Care 2014; 21: 505–513.
27. Faust K, Horn P, Schneider UC, Vajkoczy P. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome. Clin Neurol Neurosurg 2014; 125: 36–40.
28. Park JH, Park SW, Kang SH. Detection of traumatic cerebral microbleeds by susceptibility-weighted image of MRI. J Korean Neurosurg Soc 2009; 46: 365–369.
29. Gaasch JA, Lockman PR, Geldenhuys WJ. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 2007; 32: 1196–1208.
30. Glushakova OY, Johnson D, Hayes RL. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma 2014; 31: 1180–1193.
31. Donovan V, Bianchi A, Hartman R. Computational analysis reveals increased blood deposition following repeated mild traumatic brain injury. Neuroimage Clin 2012; 1: 18–28.
32. Marmarou A. Pathophysiology of traumatic brain edema: Current concepts. Acta Neurochir Suppl 2003; 86: 7–10.
33. Ewing-Cobbs L, Prasad M, Kramer L. Acute neuroradiologic findings in young children with inflicted or noninflicted traumatic brain injury. Childs Nerv Syst 2000; 16: 25–33; discussion 4.
34. Badaut J, Ashwal S, Obenaus A. Aquaporins in cerebrovascular disease: A target for treatment of brain edema? Cerebrovasc Dis 2011; 31: 521–531.
35. Nirula R, Millar D, Greene T. Decompressive craniectomy or medical management for refractory intracranial hypertension: An AAST-MIT propensity score analysis. J Trauma Acute Care Surg 2014; 76: 944–952; discussion 52–55.
36. Bouma GJ, Muizelaar JP, Stringer WA. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg 1992; 77: 360–368.
37. Soustiel JF, Glenn TC, Shik V. Monitoring of cerebral blood flow and metabolism in traumatic brain injury. J Neurotrauma 2005; 22: 955–965.
38. Bouma GJ, Muizelaar JP, Choi SC. Cerebral circulation and metabolism after severe traumatic brain injury: The elusive role of ischemia. J Neurosurg 1991; 75: 685–693.
39. Ostergaard L, Engedal TS, Aamand R. Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury. J Cereb Blood Flow Metab 2014; 34: 1585–198.
40. Doshi H, Wiseman N, Liu J. Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage. PloS One 2015; 10: e0118061.
41. Inoue Y, Shiozaki T, Tasaki O. Changes in cerebral blood flow from the acute to the chronic phase of severe head injury. J Neurotrauma 2005; 22: 1411–148.
42. Kramer DR, Winer JL, Pease BA. Cerebral vasospasm in traumatic brain injury. Neurol Res Int 2013; 2013: 415813.
43. Oertel M, Boscardin WJ, Obrist WD. Posttraumatic vasospasm: The epidemiology, severity, and time course of an underestimated phenomenon: A prospective study performed in 299 patients. J Neurosurg 2005; 103: 812–824.
44. Alford PW, Dabiri BE, Goss JA. Blast-induced phenotypic switching in cerebral vasospasm. Proc Natl Acad Sci U S A 2011; 108: 12705–12710.
45. Izzy S, Muehlschlegel S. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage and traumatic brain injury. Curr Treat Options Neurol 2014; 16: 278.
46. Dore-Duffy P, Owen C, Balabanov R. Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 2000; 60: 55–69.
47. Ho KM, Honeybul S, Yip CB. Prognostic significance of blood-brain barrier disruption in patients with severe nonpenetrating traumatic brain injury requiring decompressive craniectomy. J Neurosurg 2014; 121: 674–679.
48. Tomkins O, Shelef I, Kaizerman I. Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 2008; 79: 774–777.
49. Yeoh S, Bell ED, Monson KL. Distribution of blood-brain barrier disruption in primary blast injury. Ann Biomed Eng 2013; 41: 2206–2214.
50. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013; 13: 159–175.
51. Abdul-Muneer PM, Chandra N, Haorah J. Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol 2015; 51: 966–979.
52. Harhangi BS, Kompanje EJ, Leebeek FW. Coagulation disorders after traumatic brain injury. Acta Neurochir 2008; 150: 165–175; discussion 75.
53. Yuan Q, Sun YR, Wu X. Coagulopathy in Traumatic brain injury and its correlation with progressive hemorrhagic injury: A systematic review and meta-analysis. J Neurotrauma 2016; 33: 1279–1291.
54. de Oliveira Manoel AL, Neto AC, Veigas PV. Traumatic brain injury associated coagulopathy. Neurocrit Care 2015; 22: 34–44.
55. Lustenberger T, Talving P, Kobayashi L. Time course of coagulopathy in isolated severe traumatic brain injury. Injury 2010; 41: 924–928.
56. Midura EF, Jernigan PL, Kuethe JW. Microparticles impact coagulation after traumatic brain injury. J Surg Res 2015; 197: 25–31.
57. Ploplis VA, Donahue DL, Sandoval-Cooper MJ. Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury. J Neurotrauma 2014; 31: 1672–1675.
58. Laroche M, Kutcher ME, Huang MC. Coagulopathy after traumatic brain injury. Neurosurgery 2012; 70: 1334–1345.
59. Nakae R, Takayama Y, Kuwamoto K. Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. J Neurotrauma 2016; 33: 688–695.
60. Schnuriger B, Inaba K, Abdelsayed GA. The impact of platelets on the progression of traumatic intracranial hemorrhage. J Trauma 2010; 68: 881–885.
61. Lorente L. New prognostic biomarkers in patients with traumatic brain injury. Arch Trauma Res 2015; 4: e30165.
62. Shen X, Dutcher SK, Palmer J. A systematic review of the benefits and risks of anticoagulation following traumatic brain injury. J Head Trauma Rehabil 2015; 30: E29–E37.
63. Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 2012; 26: 1191–1201.
64. Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: A systematic review. J Trauma Acute Care Surg 2015; 78: 184–191.
65. Gentleman SM, Leclercq PD, Moyes L. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004; 146: 97–104.
66. Johnson VE, Stewart JE, Begbie FD. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 2013; 136: 28–42.
67. Smith C, Gentleman SM, Leclercq PD. The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol 2013; 39: 654–666.
68. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57–69.
69. Hernandez-Ontiveros DG, Tajiri N, Acosta S. Microglia activation as a biomarker for traumatic brain injury. Front Neurol 2013; 4: 30.
70. Siddiq I, Park E, Liu E. Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A. J Neurotrauma 2012; 29: 2647–2659.
71. Obenaus A, Ng M, Orantes A. Traumatic brain injury results in acute rarefication of the vascular network. Sci Rep 2017; 7: 239.
72. Hayward NM, Tuunanen PI, Immonen R. Magnetic resonance imaging of regional hemodynamic and cerebrovascular recovery after lateral fluid-percussion brain injury in rats. J Cereb Blood Flow Metab 2011; 31: 166–177.
73. Jia Y, Grafe MR, Gruber A. In vivo optical imaging of revascularization after brain trauma in mice. Microvasc Res 2011; 81: 73–80.
74. Rodriguez-Baeza A, Reina-de la Torre F, Poca A. Morphological features in human cortical brain microvessels after head injury: A three-dimensional and immunocytochemical study. Anat Rec Discov Mol Cell Evol Bio 2003; 273: 583–593.
75. Rafols JA, Kreipke CW, Petrov T. Alterations in cerebral cortex microvessels and the microcirculation in a rat model of traumatic brain injury: A correlative EM and laser Doppler flowmetry study. Neurol Res 2007; 29: 339–347.
76. Castejon OJ. Ultrastructural alterations of human cortical capillary basement membrane in human brain oedema. Folia Neuropathol 2014; 52: 10–21.
77. Danaila L, Popescu I, Pais V. Apoptosis, paraptosis, necrosis, and cell regeneration in posttraumatic cerebral arteries. Chirurgia 2013; 108: 319–324.
78. Jullienne A, Roberts JM, Pop V. Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation. J Cereb Blood Flow Metab 2014; 34: 1637–1645.
79. Gama Sosa MA, De Gasperi R, Janssen PL. Selective vulnerability of the cerebral vasculature to blast injury in a rat model of mild traumatic brain injury. Acta Neuropathol Commun 2014; 2: 67.
80. Lynch CE, Crynen G, Ferguson S. Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injury. Brain Injury 2016; 30: 1414–1427.
81. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298–307.
82. Skold MK, von Gertten C, Sandberg-Nordqvist AC. VEGF and VEGF receptor expression after experimental brain contusion in rat. J Neurotrauma 2005; 22: 353–367.
83. Gajavelli S, Kentaro S, Diaz J. Glucose and oxygen metabolism after penetrating ballistic-like brain injury. J Cereb Blood Flow Metab 2015; 35: 773–780.
84. Anderson J, Sandhir R, Hamilton ES. Impaired expression of neuroprotective molecules in the HIF-1alpha pathway following traumatic brain injury in aged mice. J Neurotrauma 2009; 26: 1557–1566.
85. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 2006; 59: 15–26.
86. Krum JM, Mani N, Rosenstein JM. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002; 110: 589–604.
87. Krum JM, Khaibullina A. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: Roles for VEGF in brain repair. Exp Neurol 2003; 181: 241–257.
88. Balabanov R, Goldman H, Murphy S. Endothelial cell activation following moderate traumatic brain injury. Neurol Res 2001; 23: 175–182.
89. Van Hove AH, Benoit DS. Depot-based delivery systems for pro-angiogenic peptides: A review. Front Bioeng Biotechnol 2015; 3: 102.
90. Asahara T, Masuda H, Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221–228.
91. Gong D, Zhang S, Liu L. Dynamic changes of vascular endothelial growth factor and angiopoietin-1 in association with circulating endothelial progenitor cells after severe traumatic brain injury. J Trauma 2011; 70: 1480–1484.
92. Liu L, Wei H, Chen F. Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury. Crit Care Med 2011; 39: 1760–1765.
93. Guo X, Liu L, Zhang M. Correlation of CD34+ cells with tissue angiogenesis after traumatic brain injury in a rat model. J Neurotrauma 2009; 26: 1337–1344.
94. Roncalli JG, Tongers J, Renault MA. Endothelial progenitor cells in regenerative medicine and cancer: A decade of research. Trends Biotechnol 2008; 26: 276–283.
95. Du R, Lu KV, Petritsch C. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008; 13: 206–220.
96. Liu L, Liu H, Jiao J. Changes in circulating human endothelial progenitor cells after brain injury. J Neurotrauma 2007; 24: 936–943.
97. Reale A, Melaccio A, Lamanuzzi A. Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies. Stem Cells Int 2016; 2016: 7954580.
98. Ziegelhoeffer T, Fernandez B, Kostin S. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004; 94: 230–238.
99. Urbich C, Aicher A, Heeschen C. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005; 39: 733–742.
100. Miller JT, Bartley JH, Wimborne HJ. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci 2005; 6: 63.
101. Treutiger CJ, Mullins GE, Johansson AS. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003; 254: 375–385.
102. Hayakawa K, Pham LD, Katusic ZS. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A 2012; 109: 7505–7510.
103. Hayakawa K, Miyamoto N, Seo JH. High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter. J Neurochem 2013; 125: 273–280.
104. Jones EV, Bouvier DS. Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease. Neural Plast 2014; 2014: 321209.
105. Ribotta MG, Menet V, Privat A. Glial scar and axonal regeneration in the CNS: Lessons from GFAP and vimentin transgenic mice. Acta Neurochir Suppl 2004; 89: 87–92.
106. Villapol S, Byrnes KR, Symes AJ. Temporal dynamics of cerebral blood flow, cortical damage, apoptosis, astrocyte-vasculature interaction and astrogliosis in the pericontusional region after traumatic brain injury. Front Neurol 2014; 5: 82.
107. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41–53.
108. Raza A, Franklin MJ, Dudek AZ. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 2010; 85: 593–598.
109. Zehendner CM, Sebastiani A, Hugonnet A. Traumatic brain injury results in rapid pericyte loss followed by reactive pericytosis in the cerebral cortex. Sci Rep 2015; 5: 13497.
110. Yemisci M, Gursoy-Ozdemir Y, Vural A. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009; 15: 1031–1037.
111. Hori S, Ohtsuki S, Hosoya K. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem 2004; 89: 503–513.
112. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452–464.
113. Parent JM, Vexler ZS, Gong C. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol 2002; 52: 802–813.
114. Kojima T, Hirota Y, Ema M. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells 2010; 28: 545–554.
115. Skardelly M, Gaber K, Burdack S. Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury. J Neurotrauma 2011; 28: 401–414.
116. Schiera G, Proia P, Alberti C. Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles. J Cell Mol Med 2007; 11: 1384–1394.
117. Okabe K, Kobayashi S, Yamada T. Neurons limit angiogenesis by titrating VEGF in retina. Cell 2014; 159: 584–596.
118. Hsieh CL, Kim CC, Ryba BE. Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol 2013; 43: 2010–2022.
119. Spiller KL, Anfang RR, Spiller KJ. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 2014; 35: 4477–4488.
120. Kim CC, Nakamura MC, Hsieh CL. Brain trauma elicits non-canonical macrophage activation states. J Neuroinflammation 2016; 13: 117.
121. Kumar A, Alvarez-Croda DM, Stoica BA. Microglial/macrophage polarization dynamics following traumatic brain injury. J Neurotrauma 2016; 33: 1732–1750.
122. Frautschy SA, Walicke PA, Baird A. Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res 1991; 553: 291–299.
123. Lobov IB, Rao S, Carroll TJ. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 2005; 437: 417–421.
124. Liu C, Wu C, Yang Q. Macrophages mediate the repair of brain vascular rupture through direct physical adhesion and mechanical traction. Immunity 2016; 44: 1162–1176.
125. Fantin A, Vieira JM, Gestri G. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010; 116: 829–840.
126. He H, Mack JJ, Guc E. Perivascular macrophages limit permeability. Arterioscler Thromb Vasc Biol 2016; 36: 2203–2212.
127. Zhang Z, Zhang ZY, Wu Y. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury. Brain Res 2012; 1461: 102–110.
128. Lin EY, Li JF, Gnatovskiy L. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006; 66: 11238–11246.
129. Addington CP, Roussas A, Dutta D. Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration. Biomark Insights 2015; 10: 43–60.
130. Thau-Zuchman O, Shohami E, Alexandrovich AG. Subacute treatment with vascular endothelial growth factor after traumatic brain injury increases angiogenesis and gliogenesis. Neuroscience 2012; 202: 334–341.
131. Thau-Zuchman O, Shohami E, Alexandrovich AG. Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury. J Mol Neurosci 2012; 47: 166–172.
132. Zhang ZG, Zhang L, Tsang W. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002; 22: 379–392.
133. Zhang A, Liang L, Niu H. Protective effects of VEGF treatment on focal cerebral ischemia in rats. Mol Med Rep 2012; 6: 1315–1318.
134. Dzietko M, Derugin N, Wendland MF. Delayed VEGF treatment enhances angiogenesis and recovery after neonatal focal rodent stroke. Transl Stroke Res 2013; 4: 189–200.
135. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006; 312: 549–560.
136. Koch S, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2012; 2: a006502.
137. Gong D, Hao M, Liu L. Prognostic relevance of circulating endothelial progenitor cells for severe traumatic brain injury. Brain Injury 2012; 26: 291–297.
138. Li W, Wang H, Kuang CY. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 2012; 363: 135–145.
139. Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol 2013; 14: 166–180.
140. Kano MR, Morishita Y, Iwata C. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 2005; 118: 3759–3768.
141. Wang ZG, Cheng Y, Yu XC. bFGF protects against blood-brain barrier damage through junction protein regulation via pi3k-akt-rac1 pathway following traumatic brain injury. Mol Neurobiol 2015; 53: 7298–7311.
142. Huang B, Krafft PR, Ma Q. Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice. Neurobiol Dis 2012; 46: 204–214.
143. Li S, Wei M, Zhou Z. SDF-1alpha induces angiogenesis after traumatic brain injury. Brain Res 2012; 1444: 76–86.
144. Sun W, Liu J, Huan Y. Intracranial injection of recombinant stromal-derived factor-1 alpha (SDF-1alpha) attenuates traumatic brain injury in rats. Inflamm Res 2014; 63: 287–297.
145. Cencioni C, Capogrossi MC, Napolitano M. The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res 2012; 94: 400–407.
146. Wu Y, Yoder A. Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. PLoS Pathog 2009; 5: e1000520.
147. Rosenkranz K, Kumbruch S, Lebermann K. The chemokine SDF-1/CXCL12 contributes to the ‘homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. J Neurosci Res 2010; 88: 1223–1233.
148. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161–174.
149. van Hinsbergh VW, Koolwijk P. Endothelial sprouting and angiogenesis: Matrix metalloproteinases in the lead. Cardiovasc Res 2008; 78: 203–212.
150. Lee S, Jilani SM, Nikolova GV. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005; 169: 681–691.
151. Frontczak-Baniewicz M, Walski M. MMP2 and MMP9 in immature endothelial cells following surgical injury of rat cerebral cortex – A preliminary study. Folia Neuropathol 2009; 47: 338–346.
152. Huang PH, Chen YH, Wang CH. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009; 29: 1179–1184.
153. Heissig B, Hattori K, Dias S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625–637.
154. Gurbel PA, Roe MT, Jakubowski JA. Translational platelet research in patients with coronary artery disease: What are the major knowledge gaps? Thromb Haemost 2012; 108: 12–20.
155. Chen J, Cui X, Zacharek A. Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med 2009; 13: 1348–1357.
156. Nourhaghighi N, Teichert-Kuliszewska K, Davis J. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest 2003; 83: 1211–1222.
157. Echavarria R, Hussain SN. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5. J Am Heart Assoc 2013; 2: e000571.
158. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res 2004; 1000: 19–31.
159. Meng Y, Xiong Y, Mahmood A. Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats. J Neurosurg 2011; 115: 550–560.
160. Cherian L, Goodman JC, Robertson C. Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J Pharmacol Exp Ther 2007; 322: 789–794.
161. Tsai PT, Ohab JJ, Kertesz N. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 2006; 26: 1269–1274.
162. Sautina L, Sautin Y, Beem E. Induction of nitric oxide by erythropoietin is mediated by the {beta} common receptor and requires interaction with VEGF receptor 2. Blood 2010; 115: 896–905.
163. Wang L, Chopp M, Gregg SR. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab 2008; 28: 1361–1368.
164. Wang L, Wang X, Su H. Recombinant human erythropoietin improves the neurofunctional recovery of rats following traumatic brain injury via an increase in circulating endothelial progenitor cells. Transl Stroke Res 2015; 6: 50–59.
165. Hirata A, Minamino T, Asanuma H. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 2006; 48: 176–184.
166. Yip HK, Tsai TH, Lin HS. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care 2011; 15: R40.
167. Yokota H, Naoe Y, Nakabayashi M. Cerebral endothelial injury in severe head injury: The significance of measurements of serum thrombomodulin and the von Willebrand factor. J Neurotrauma 2002; 19: 1007–1015.
168. Rauch A, Wohner N, Christophe OD. On the versatility of von Willebrand factor. Mediterr J Hematol Infect Dis 2013; 5: e2013046.
169. Lenting PJ, Casari C, Christophe OD. von Willebrand factor: The old, the new and the unknown. J Thromb Haemost 2012; 10: 2428–2437.
170. Zhang J, Jiang R, Liu L. Traumatic brain injury-associated coagulopathy. J Neurotrauma 2012; 29: 2597–2605.
171. Starke RD, Ferraro F, Paschalaki KE. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011; 117: 1071–1080.
172. Randi AM, Laffan MA, Starke RD. Von Willebrand factor, angiodysplasia and angiogenesis. Mediterr J Hematol Infect Dis 2013; 5: e2013060.
173. Wagner DD, Frenette PS. The vessel wall and its interactions. Blood 2008; 111: 5271–5281.
174. Lambert C, Cisternas P, Inestrosa NC. Role of Wnt signaling in central nervous system injury. Mol Neurobiol 2015; 53: 2297–2311.
175. White BD, Nathe RJ, Maris DO. Beta-catenin signaling increases in proliferating NG2+ progenitors and astrocytes during post-traumatic gliogenesis in the adult brain. Stem Cells 2010; 28: 297–307.
176. Zhang L, Yan R, Zhang Q. Survivin, a key component of the Wnt/beta-catenin signaling pathway, contributes to traumatic brain injury-induced adult neurogenesis in the mouse dentate gyrus. Int J Mol Med 2013; 32: 867–875.
177. Shapira M, Licht A, Milman A. Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. Mol Cell Neurosci 2007; 34: 571–577.
178. Wu X, Mao H, Liu J. Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury. Int J Clin Exp Pathol 2013; 6: 1282–1293.
179. Birdsey GM, Shah AV, Dufton N. The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/beta-catenin signaling. Dev Cell 2015; 32: 82–96.
180. Zhou Y, Wang Y, Tischfield M. Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest 2014; 124: 3825–3846.
181. Corada M, Nyqvist D, Orsenigo F. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 2010; 18: 938–949.
182. Corada M, Morini MF, Dejana E. Signaling pathways in the specification of arteries and veins. Arterioscler Thromb Vasc Biol 2014; 34: 2372–2377.
183. Qu B, Liu BR, Du YJ. Wnt/beta-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett 2014; 7: 1175–1178.
184. Ghosh N, Yuan X, Turenius CI. Automated core-penumbra quantification in neonatal ischemic brain injury. J Cereb Blood Flow Metab 2012; 32: 2161–2170.
185. Liu J, Wang Y, Akamatsu Y. Vascular remodeling after ischemic stroke: Mechanisms and therapeutic potentials. Prog Neurobiol 2014; 115: 138–156.
186. Lin CY, Chang C, Cheung WM. Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: Evaluation with contrast-enhanced magnetic resonance imaging. J Cereb Blood Flow Metab 2008; 28: 1491–1501.
187. Krupinski J, Stroemer P, Slevin M. Three-dimensional structure and survival of newly formed blood vessels after focal cerebral ischemia. Neuroreport 2003; 14: 1171–1176.
188. Krupinski J, Kaluza J, Kumar P. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994; 25: 1794–1798.
189. Petcu EB, Smith RA, Miroiu RI. Angiogenesis in old-aged subjects after ischemic stroke: A cautionary note for investigators. J Angiogenes Res 2010; 2: 26.
190. Overstreet DJ, Dutta D, Stabenfeldt SE. Injectable hydrogels. J Polym Sci Part B 2012; 50: 881–903.
191. Atta S, Khaliq S, Islam A. Injectable biopolymer based hydrogels for drug delivery applications. Int J Biol Macromol 2015; 80: 240–245.
192. Argaw AT, Asp L, Zhang J. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 2012; 122: 2454–2468.
193. Zhang ZG, Zhang L, Jiang Q. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829–838.
194. Valable S, Montaner J, Bellail A. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: Both effects decreased by Ang-1. J Cereb Blood Flow Metab 2005; 25: 1491–1504.
195. Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002; 125: 2549–2557.
196. Vaquero J, Zurita M. Functional recovery after severe CNS trauma: Current perspectives for cell therapy with bone marrow stromal cells. Prog Neurobiol 2011; 93: 341–349.
197. Mahmood A, Lu D, Wang L. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 2001; 49: 1196–1203; discussion 203–204.
198. Mahmood A, Lu D, Yi L. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg 2001; 94: 589–595.
199. Mahmood A, Lu D, Qu C. Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg 2006; 104: 272–277.
200. Jiang J, Bu X, Liu M. Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury. Neural Regen Res 2012; 7: 46–53.
201. Hu W, Liu J, Jiang J. [Effect of bone marrow mesenchymal stem cells on angiogenesis in rats after brain injury]. Zhong Nan da Xue Xue Bao Yi Xue Ban = J Central South Univer Med Sci 2016; 41: 489–495.
202. Wang Z, Wang Y, Wang Z. Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury. Stem Cells 2015; 33: 456–467.
203. Zhang Y, Chopp M, Meng Y. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 2015; 122: 856–867.
204. Zhang ZX, Guan LX, Zhang K. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy 2008; 10: 134–139.
205. SimWu H, Jiang H, Lu D. Induction of angiogenesis and modulation of vascular endothelial growth factor receptor-2 by simvastatin after traumatic brain injury. Neurosurgery 2011; 68: 1363–1371. discussion 71.
206. Krum JM, Mani N, Rosenstein JM. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 2008; 212: 108–117.
207. Seghezzi G, Patel S, Ren CJ. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 1998; 141: 1659–1673.
208. Salvucci O, Yao L, Villalba S. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002; 99: 2703–2711.
209. Yamaguchi J, Kusano KF, Masuo O. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322–1328.
210. Xiong Y, Zhang Y, Mahmood A. Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor. Transl Stroke Res 2011; 2: 619–632.